News Releases

Browse press releases to learn more about products, clinical trial results, and other exciting news at Inspiration.

4/17/2012 - Inspiration Files Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B

4/17/2012 - Inspiration Supports World Hemophilia Day 2012 with Activities in Cambridge, MA

2/22/2012 - Inspiration Highlights Positive Data on its rFIX for People with Hemophilia B Who Have Undergone Major Surgical Procedures

12/22/2011 - Inspiration Moves Corporate Headquarters to Cambridge, Massachusetts

12/22/2011 - Inspiration Expands Leadership Team with Four New Hires

12/12/2011 -  Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH)

11/28/2011 - Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1

10/3/2011 - Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B

9/20/2011 - CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001

8/30/2011 - Inspiration Biopharmaceuticals and Ipsen Expand Partnership

7/28/2011 - Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia

4/15/2011 - Inspiration Biopharmaceuticals Recognizes World Hemophilia Day  - April 17

2/3/2011 - Inspiration Demonstrates Non-Inferiority of IB1001

2/3/2011 - EAHAD 2011 Poster - Pharmacokinetics of IB1001

11/19/2010 - Inspiration Treats First Patient in Pivotal Study of OBI-1 for Acquired Hemophilia A

11/5/2010 - Inspiration Awarded Two Grants Under the Qualifying Therapeutic Discovery Projects Grant Program

11/3/2010 - Inspiration Appoints Karen A. Dawes to the Company's Board of Directors

10/19/2010 - OBI-1 Receives Orphan Drug Designation in Europe

1/21/2010 - Ipsen and Inspiration Enter into Partnership

2/25/2009 - Inspiration Initiates Phase 1 Clinical Trial of IB1001

11/13/2007 - Filing of IND for Novel Recombinant Factor IX Product, IB1001

7/11/2007 - Inspiration Presents At ISTH Annual Meeting